Company news

Onco-Innovations Ltd. news in 2025

Onco-Innovations Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care

December 9, 2025

Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering

December 7, 2025

Onco-Innovations Attends University of Alberta's 2025 Innovation Awards

November 25, 2025

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies

November 20, 2025

Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development

November 18, 2025

Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment

November 7, 2025

Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight

October 31, 2025

Onco-Innovations Appoints Jared Rushton to Board of Directors

October 30, 2025

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology

September 28, 2025

Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies

September 19, 2025

Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care

September 12, 2025

Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board

September 5, 2025

Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised

August 15, 2025

Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement

August 4, 2025

Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board

July 20, 2025

Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology

July 11, 2025

Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair

July 10, 2025

Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials

July 4, 2025

Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call

July 2, 2025

Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium

June 27, 2025

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025

June 25, 2025

Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers

June 13, 2025

Onco-Innovations' Inka Health to Launch Global AI-Oncology Consortium to Advance Predictive Cancer Research

June 5, 2025

Onco-Innovations Announces Start of Manufacturing of Preclinical Testing Material for Its PNKP Inhibitor Technology by Dalton Pharma

May 26, 2025

Onco-Innovations Extends Marketing Program

May 26, 2025

Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada

May 16, 2025

Decks in 2025